INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the third quarter of 2025 and provided an update on recent company developments.

Nov 11, 2025 - 01:00
 0  14
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the third quarter of 2025 and provided an update on recent company developments.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow